Clinical Trial Update: Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing caspofungin to amphotericin B deoxycholate for invasive candidiasis in neonates and infants was terminated; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• Caspofungin (caspofungin)
• amphotericin B deoxycholate (amphotericin B deoxycholate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Candidiasis, Invasive | Phase 2 | Status: TERMINATED | Results posted: 2018-08-28